Kensey Nash Reports Second Quarter EPS of $0.21 and Revenue of $19...(le period of the prior fiscalyear and $2...),Health

Earnings Per Share. The Company reported earnings per share of $0.19 for the six-months ended December 31, 2007 compared to $0.24 diluted earnings per share for the six months ended December 31, 2006. Earnings per share included pre-tax charges of $3.0 million, or $0.16 per share tax-effected, for the acceleration of stock awards and approximately $325,000, or $0.02 per share tax-effected, of charges related to the discontinuation of the Company's embolic protection platform, incurred during the first quarter of fiscal 2008. Adjusted earnings per share, excluding these charges, was $0.36 for the six months ending December 31, 2007, a 50% increase over the prior year six-month period.

In the six-month period ended December 31, 2007, the total tax-effected impact on earnings per share of equity compensation expense was $0.23, of which $0.16 related to the acceleration of stock awards and $0.08 related to equity compensation expense prior to the acceleration, equity compensation from current year equity grants as well as a mark-to-market adjustment on Stock Appreciation Rights. The tax-effected impact on earnings per share of equity compensation expense was $0.09 in the six-month period ended December 31, 2006.

The following chart summarizes the Company's results for the six months ended December 31, 2007, compared to its results for the comparable period in the prior fiscal year. See attached schedules for a detailed reconciliation between the non-GAAP and reported GAAP results.

Six Months Year over

Ended December 31, Year %

($ millions, except per share data) 2007 2006 Change

Data As Reported:

Net Sa
'/>"/>